Stock Overview
Axsome Therapeutics Inc (AXSM)
NASDAQ · Healthcare · Biotechnology
Axsome Therapeutics Inc is a Healthcare company with a market capitalization of $12.44B.
Market Cap
$12.44B
Forward P/E
333.3
Price/Sales
17.6
Price/Book
227.8
EV/EBITDA
-14.8
Beta
0.60
EPS (TTM)
$-3.72
Profit Margin
-26.6%
ROE
-349.4%
52W High
$260.19
52W Low
$96.09
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Revenue
$638.50M
Gross Profit
$591.02M
Operating Income
-$169.24M
Net Income
-$183.17M
Free Cash Flow
-$93.89M
Total Debt
$190.72M
Cash & Equivalents
$322.93M
Shareholder Equity
$88.30M
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 4, 2026 | $-1.26 | $-0.86 | -46.5% |
| Q4 2025 | February 23, 2026 | $-0.56 | $-0.73 | +22.8% |
| Q3 2025 | November 3, 2025 | $-0.94 | $-0.90 | -4.4% |
| Q2 2025 | August 4, 2025 | $-0.97 | $-1.09 | +11.0% |
| Q1 2025 | May 5, 2025 | $-1.22 | $-1.35 | +9.6% |
| Q4 2024 | February 18, 2025 | $-1.54 | $-1.00 | -53.6% |
Other Biotechnology Stocks
Frequently Asked Questions
What is Axsome Therapeutics Inc's market cap?
As of June 29, 2026, Axsome Therapeutics Inc (AXSM) has a market capitalization of $12.44B.
Does Axsome Therapeutics Inc pay a dividend?
Axsome Therapeutics Inc does not currently pay a dividend.
What sector is AXSM in?
Axsome Therapeutics Inc is in the Healthcare sector, specifically the Biotechnology industry.
What was Axsome Therapeutics Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Axsome Therapeutics Inc reported revenue of $638.50M and net income of -$183.17M.
Ask your own questions about AXSM
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.